Breast cancer immunotherapy: mechanisms of immune evasion, biomarkers, and emerging therapeutic strategies.

Saved in:
Bibliographic Details
Title: Breast cancer immunotherapy: mechanisms of immune evasion, biomarkers, and emerging therapeutic strategies.
Authors: Shichkin VP; Aktipharm LLC, Kyiv, 02141, Ukraine. valentin.shichkin@gmail.com.; Department of Biotechnology, Faculty of Health Sciences, National University Kyiv Aviation Institute, Kyiv, 03058, Ukraine. valentin.shichkin@gmail.com., Morva A; Climat Change and Life Sciences, Biotechnology Research Group, TUBITAK Marmara Research Center, Kocaeli, 41470, Türkiye.; Transplant Immunology Research Center of Excellence TIREX, School of Medicine, Koc University, Istanbul, 34010, Türkiye., Ulaganathan VK; Institute of Medical Genetics and Applied Genomics, Universitätsklinikum Tübingen, 72076, Tübingen, Germany., Erin N; Department of Medical Pharmacology, School of Medicine, Akdeniz University, Antalya, 07070, Türkiye., Nativi C; Department of Chemistry, University of Florence, Sesto F.no, Firenze, 50019, Italy., Brezar SK; Department of Experimental Oncology Ljubljana, Institute of Oncology Ljubljana, Ljubljana, SI-1000, Slovenia., Rani S; Pharmaceutical and Molecular Biotechnology Research Centre (PMBRC), Waterford, X91 K0EK, Ireland.
Source: Molecular cancer [Mol Cancer] 2026 Apr 25; Vol. 25 (1). Date of Electronic Publication: 2026 Apr 25.
Publication Type: Journal Article; Review
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-4598
DOI:10.1186/s12943-026-02655-0